Development and validation of a pharmacogenomics reporting workflow based on the illumina global screening array chip

Keyphrases

• Illumina 100%
• Pharmacogenomics 100%
• Array chip 100%
• Global Screening Array 100%
• Validation Studies 75%
• Genetic Testing 75%
• Diplotype 75%
• Accuracy Assessment 50%
• Preclinical Validation 50%
• Star Alleles 50%
• Microarray 25%
• Further Development 25%
• Complex Disease 25%
• Analytical Sensitivity 25%
• Research Application 25%
• Disease Risk Prediction 25%
• Sample Analysis 25%
• Cost-effective Solution 25%
• Common Variants 25%
• Genetic Studies 25%
• Human Genome 25%
• Concordance Rate 25%
• Clinical Reporting 25%
• Comprehensive Validation 25%
• Genotype Calling 25%
• Adopted Technologies 25%
• 1000 Genomes Project 25%
• Assay Performance 25%
• Truth Set 25%
• Precision Assessment 25%
• Nutrigenetics 25%
• Chip Design 25%

Biochemistry, Genetics and Molecular Biology

• Genetic Screening 100%
• Pharmacogenomics 100%
• Genotyping 66%
• Allele 66%
• Genetics 33%
• Solution and Solubility 33%
• Human Genome 33%
• Pharmacogenetic Testing 33%

Immunology and Microbiology

• Genetic Screening 100%
• Pharmacogenomics 100%
• Allele 66%
• Solution and Solubility 33%
• Cell Line 33%
• Human Genome 33%
• Pharmacogenetic Testing 33%